Company Overview of 1QB Information Technologies Inc.
1QB Information Technologies Inc. provides 1QBit Quantum-Ready software solutions and consulting services for finance, energy, life sciences, and other industries. It offers classical and quantum algorithms with practical applications for intractable problems. The company was founded in 2012 and is based in Vancouver, Canada.
458 – 550 Burrard Street
Vancouver, BC V6C 2B5
Founded in 2012
Key Executives for 1QB Information Technologies Inc.
Co-Founder and Chief Executive Officer
Co-Founder and Head of Research
Compensation as of Fiscal Year 2017.
1QB Information Technologies Inc. Key Developments
The Dow Chemical Company and 1QB Information Technologies Announce Collaboration Agreement to Develop Quantum Computing Tools for the Chemicals and Materials Science Technology Spaces
Jun 21 17
The Dow Chemical Company and 1QB Information Technologies announce a collaboration agreement to develop quantum computing tools for the chemicals and materials science technology spaces. By combining Dow’s unique innovation capabilities with 1QBit’s leading expertise in the development of applications for quantum computing, the two companies will accelerate the deployment of quantum computing across a range of applications relevant to the chemical sector. The collaboration will augment Dow’s discovery process by building strong fundamental understanding of new chemicals and materials. The combination of next-generation computational methodologies with experimental design will drive new acceleration of product and process development. The mission of 1QBit is to apply breakthroughs in computation to machine intelligence and optimization science through a widely accessible, hardware-agnostic software platform. Over the last four years, 1QBit has developed new methods for machine learning, sampling, and optimization based on reformulating problems to meet the unique requirements of interfacing with quantum computers and leveraging their capabilities.
Accenture Labs and 1QBit Work with Biogen to Apply Quantum Computing to Accelerate Drug Discovery
Jun 14 17
Accenture and 1QBit collaborated with Biogen to develop a quantum-enabled molecular comparison application that could significantly improve advanced molecular design to speed up drug discovery for complex neurological conditions such as multiple sclerosis, Alzheimer’s, Parkinson’s and Lou Gehrig’s Disease. Researchers at Accenture Labs collaborated with 1QBit to create the new application which enhances Biogen’s existing molecule comparison method with quantum capabilities. Molecular comparison is a crucial part of early-phase drug design and discovery, and involves intensive computational methods to review molecule matches and predict the positive effects of a therapy or drug while reducing negative side effects. By leveraging quantum computing – a computing paradigm that has the potential to find the answer to complex business problems millions of times faster than classical computing by leveraging the properties of quantum physics – the new application provides novel insights into the molecular comparison process as well as much deeper contextual information about how, where and why molecules match. This is expected to enable scientists and researchers to analyze large collections of molecules more quickly and cost effectively.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries